In contrast, treatment with N(G)-nitro-L-arginine methyl ester (L-NAME, a pan-NOS inhibitor) had more consistent findings and resulted in exacerbation of cystic kidney disease and hypertension [13, 15]. This evidence concerns the gene NOS1 and cystic kidney disease.